Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
  1. Homepage
  2. Equities
  3. Switzerland
  4. Swiss Exchange
  5. Novartis AG
  6. Revisions
    NOVN   CH0012005267

NOVARTIS AG

(NOVN)
  Report
Real-time Estimate Cboe Europe  -  09:01 2022-12-08 am EST
85.34 CHF   -0.52%
07:15aNovartis Says Phase 3 Trial of Experimental Blood Disease Drug Met Main Endpoint
MT
01:57aNovartis Phase 3 Trial for Hemoglobinuria Drug Iptacopan Met Primary Endpoint
DJ
01:38aNovartis' Rare Blood Disease Drug Improves Hemoglobin Levels in Late-stage Study
MT
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
Earnings Per Share (EPS): Change in analysts' estimates
Turnover: Change in analysts' estimates
EPS consensus revisions
Next year EPS consensus revisions
Revenue consensus revisions
Next year Revenue consensus revisions